Prelude Therapeutics
$74.459876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$74.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.72 (-0.96%) Today
$0.00 (0.00%) As of 9:07 PM UTC after-hours
Why Robinhood?
You can buy or sell PRLD and other stocks, options, and ETFs commission-free!
About PRLD
Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE. The listed name for PRLD is Prelude Therapeutics Incorporated Common Stock.
CEO
Krishna Vaddi
Employees
—
Headquarters
Wilmington, Delaware
Founded
2016
Market Cap
3.40B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
385.29K
High Today
$76.75
Low Today
$72.04
Open Price
$74.94
Volume
240.87K
52 Week High
$89.06
52 Week Low
$23.69
Collections
PRLD Earnings
-$5.25
-$3.50
-$1.75
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 24, Pre-Market